Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült Államok2. fázis

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

A legfontosabb adatok

Hol
Albuquerque, Amherst, Atlanta, Aurora, Baltimore, Birmingham, Boston, Charleston, Chicago, Cincinnati, Dallas, Denver, East Lansing, Farmington Hills, Fayetteville, Gainesville, Georgetown, Houston, Irvine, Kirkland, Los Angeles, Memphis, Miami, Nashville, New York, Olney, Orlando, Overland Park, Philadelphia, Portland, Richmond, Rochester, Sacramento, Scottsdale, Spokane, St Louis, Sun City és Vernon (Egyesült Államok)Mind a 41 helyszín megnézése
Fázis
2. fázis

Neked szólhat?

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 70 év között vagy?

Forrás: NCT07304089: ki vehet részt

Helyszínek itt: Egyesült Államok

  • Albuquerque, New MexicoHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Amherst, New YorkHospital not named in the registryContact: Study DirectorToborzás még nem indult
  • Atlanta, GeorgiaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Aurora, ColoradoHospital not named in the registryContact: Study DirectorToborzás még nem indult
  • Baltimore, MarylandHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Birmingham, AlabamaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Boston, MassachusettsHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Charleston, South CarolinaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Chicago, IllinoisHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Cincinnati, OhioHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Dallas, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Denver, ColoradoHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • East Lansing, MichiganHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Farmington Hills, MichiganHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Fayetteville, North CarolinaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Gainesville, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Georgetown, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Houston, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Houston, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Irvine, CaliforniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Kirkland, WashingtonHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Los Angeles, CaliforniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Memphis, TennesseeHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Miami, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Nashville, TennesseeHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • New YorkHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • New YorkHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Olney, MarylandHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Orlando, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Overland Park, KansasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Philadelphia, PennsylvaniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Portland, OregonHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Richmond, VirginiaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Rochester, New YorkHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Sacramento, CaliforniaHospital not named in the registryContact: Study DirectorToborzás még nem indult
  • Scottsdale, ArizonaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Scottsdale, ArizonaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Spokane, WashingtonHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • St Louis, MissouriHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Sun City, ArizonaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Vernon, ConnecticutHospital not named in the registryContact: Study DirectorToborzás még nem indult

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Vima Therapeutics
Azonosító
NCT07304089
A regiszteradat frissítve
2026. október 26.
Eredeti leírás
Stride Dystonia is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isolated dystonia.A teljes eredeti leírásKevesebb

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia (Stride Dystonia)

Stride Dystonia is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isolated dystonia.

The main objectives of this clinical trial are to determine the following:

* Does VIM0423 therapy improve dystonia symptoms compared to placebo? * Is VIM0423 well tolerated in individuals with isolated dystonia? and * Do the therapeutic effects of VIM0423 confer improvements on daily function and quality of life?

Bevonási feltételek: Participant must be male or nonpregnant female between 18 and 70 years of age (inclusive) at Visit 1 (Screening); The participant has a clinical diagnosis of isolated dystonia with symptoms consistent with dystonia for at least one year prior to Visit 1 (Screening); has two or more body regions affected by dystonia at Visit 1 (Screening); and has been confirmed by Investigator and Enrollment Authorization Committee; The participant may be untreated with BoNT; OR if the participant is being treated with BoNT as part of their standard of care for dystonia, they must meet protocol-specified criteria; The participants must meet protocol-specified requirements for baseline scores on the BFM and CGI-S.

ClinicalTrials.gov NCT07304089